PharmaCorp Rx (TSXV:PCRX) Interest Expense: C$-0.14 Mil (TTM As of Mar. 2026)


TSXV:PCRX PharmaCorp Rx Inc TSXV:PCRX
36 GF Score
Price C$0.50
! 2 Warning Signs
View Full Analysis

What is PharmaCorp Rx Interest Expense?

PharmaCorp Rx TSXV:PCRX -1.96% 36 Interest Expense is C$-0.14 Mil as of Mar. 2026. GuruFocus rates TSXV:PCRX with a GF Score™ of 36/100. The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. PharmaCorp Rx's interest expense for the three months ended in Mar. 2026 was C$ -0.05 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was C$-0.14 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. PharmaCorp Rx's Operating Income for the three months ended in Mar. 2026 was C$ -0.05 Mil. PharmaCorp Rx's Interest Expense for the three months ended in Mar. 2026 was C$ -0.05 Mil. PharmaCorp Rx did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PharmaCorp Rx  (TSXV:PCRX) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PharmaCorp Rx's Interest Expense for the three months ended in Mar. 2026 was C$-0.05 Mil. Its Operating Income for the three months ended in Mar. 2026 was C$-0.05 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was C$3.94 Mil.

PharmaCorp Rx's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

PharmaCorp Rx did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

PharmaCorp Rx Interest Expense Historical Data

* Premium members only.

The historical data trend for PharmaCorp Rx's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCorp Rx Interest Expense Chart

PharmaCorp Rx Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
0.00 0.00 0.00 -0.03 -0.10

PharmaCorp Rx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.02 -0.05 -0.05
TSXV:PCRX
36GF Score
PharmaCorp Rx Inc TSXV:PCRX
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaCorp Rx Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of C$-0.14 Mil mean?
PharmaCorp Rx (TSXV:PCRX) has a Interest Expense of C$-0.14 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on PharmaCorp Rx and its competitors.
Is PharmaCorp Rx's Interest Expense too high?
PharmaCorp Rx's current Interest Expense is C$-0.14 Mil. Overall, PharmaCorp Rx has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's Interest Expense compare to competitors?
PharmaCorp Rx's Interest Expense of C$-0.14 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Healthcare Providers & Services company?
A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on PharmaCorp Rx and its competitors. PharmaCorp Rx's current Interest Expense is C$-0.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current Interest Expense of C$-0.14 Mil. The current Interest Expense is C$-0.14 Mil. PharmaCorp Rx's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current Interest Expense is C$-0.14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCorp Rx Business Description

Address 303 Wellman Lane, Suite 203, Saskatoon, SK, CAN, S7T 0J1
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
36GF Score

Get the complete analysis for TSXV:PCRX

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.50
Price